Stroke therapy

Carolyn D Brockington MD (Dr. Brockington, Director of the Stroke Center at St. Luke's-Roosevelt Hospital, has no relevant financial relationships to disclose.)
Steven R Levine MD, editor. (Dr. Levine of the SUNY Health Science Center at Brooklyn has received honorariums from Genentech for service on a scientific advisory committee and a research grant from Genentech as a principal investigator.)
Originally released August 14, 2001; last updated November 22, 2016; expires November 22, 2019


Stroke treatment is an emergency, and options for treatment have increased since the FDA approval of intravenous t-PA use in acute ischemic stroke in 1996. This update contains information on various topics in the treatment of acute stroke, including the use of combination antiplatelet therapy in patients with minor stroke or transient ischemic attack, and the latest on blood pressure management in the setting of intracerebral hemorrhage.

The content you are trying to view is available only to logged in, current MedLink Neurology subscribers.

If you are a subscriber, please log in.

If you are a former subscriber or have registered before, please log in first and then click select a Service Plan or contact Subscriber Services. Site license users, click the Site License Acces link on the Homepage at an authorized computer.

If you have never registered before, click Learn More about MedLink Neurology  or view available Service Plans.